马春红教授
国家自然科学基金杰出青年基金、中组部“万人计划”领军人才、教育部“新世纪优秀人才支持计划”、霍英东基金会高等院校青年教师基金、山东省杰出青年基金获得者，全国三八红旗手。Cell Report、Liver international、Cancer Biology Therapy等杂志审稿人。现任山东大学齐鲁医学院副院长、教育部实验畸形学重点实验室主任。山东免疫学会常务理事、山东免疫学基础专业委员会主任委员。长期从事肝病与免疫研究，致力于研究HBV、代谢等环境因素诱发肝脏炎症及其恶性转化的分子机制及干... More+
- 暂无内容
- 许志亮. Upregulation of IL-6 in CUL4B-deficient myeloid-derived suppressive cells increases the aggressiveness of cancer cells. oncogene, 38, 5860, 2022.
- 谭思雨. Transcription factor Zhx2 restricts NK cell maturation and suppresses their antitumor immunity. Journal of Experimental Medicine, 218, 2022.
- 王体潇. Spatial distribution and functional analysis define the action pathway of Tim-3/Tim-3 ligands in tumor development. MOLECULAR THERAPY, 2022.
- 程洋. Phosphoinositide-Binding Protein TIPE1 Promotes Alternative Activation of Macrophages and Tumor Progression via PIP3/Akt/TGFβ Axis. cancer research, 2022.
- 刘蕾. Upregulation of TIPE1 in tubular epithelial cell aggravates diabetic nephropathy by disrupting PHB2 mediated mitophagy. Redox Biol, 2022.
- 续力云. Hepatic Macrophage as a Key Player in Fatty Liver Disease. Frontiers in Immunology, 12, 2022.
- 赵松柏. Surface specifically modified NK-92 cells with CD56 antibody conjugated superparamagnetic Fe3O4 nanoparticles for magnetic targeting immunotherapy of solid tumors. NANOSCALE, 13, 19109, 2022.
- 陈思源. N-Glycosylation at Asn291 Stabilizes TIM-4 and Promotes the Metastasis of NSCLC. FRONTIERS IN ONCOLOGY, 12, 2022.
-
介导HBV肝脏免疫耐受/耗竭的关键卡控点的发现与验证, 2021/12/01-2024/11/30
-
肿瘤免疫逃逸关键抑制分子的鉴定及多靶向纳米抗体制备, 2020/12/16-2023/12/31
-
肿瘤免疫逃逸关键抑制分子的鉴定及多靶向纳米抗体制备, 2020/12/16-2023/12/31
-
mTOR抑制剂对持续低剂量率照射肝癌放射敏感性的影响与信号传导通路调控, 2018/03/01-2020/06/01
-
射频消融改造肿瘤相关巨噬细胞在肝癌免疫治疗中的意义, 2017/01/01-2019/12/31
-
sTim-4干预非小细胞肺癌转移的基础与转化研究, 2019/12/19-2022/12/31
-
TRAIL和IKB联合治疗HBV相关性肝癌的实验研究, 2004/12/10-2006/12/30
-
Egfl7在角膜新生血管形成中的作用及其机制研究, 2006/12/10-2008/12/30